Hyphen BioMed Overview

  • Founded
  • 1999
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 80
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Hyphen BioMed General Information

Description

Operator of a technical and innovative, scientific company intended to propose a full line of diagnostic and research reagents to be distributed worldwide. The company's diagnostic and research reagents are available worldwide, through a network of specialised distributors, or directly from the company and its laboratories are equipped with analytical instruments and with highly performing manufacturing machines and quality control analyzers enabling the company to conceive, manufacture, market and develop research and biomedical in vitro diagnostic reagents for the exploration of Thrombosis, Haemostasis and Auto-Immunity. It owns a complete range of analytical equipment for immunological, clotting and chromogenic methods, cell culture, production of recombinant proteins, engineering and purification of proteins from plasma or biological extracts.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Other Chemicals and Gases
Drug Discovery
Parent Company
Primary Office
  • ZAC Neuville-Université
  • 155 Rue d'Eragny
  • 95000 Neuville-sur-Oise
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hyphen BioMed Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hyphen BioMed‘s full profile, request access.

Request a free trial

Hyphen BioMed Executive Team (2)

Name Title Board Seat Contact Info
Anne-Marie Vissac Co-Founder & President
Jean Amiral Ph.D Co-Founder, President & Scientific and Research Director
To view Hyphen BioMed’s complete executive team members history, request access »

Hyphen BioMed Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hyphen BioMed Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Hyphen BioMed‘s full profile, request access.

Request a free trial